共 50 条
- [2] Sulfonylureas as second line drugs in type 2 diabetes and the risk of cardiovascular and hypoglycaemic events: population based cohort study BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
- [6] Sulfonylurea and Cancer Risk Among Patients With Type 2 Diabetes: A Population-Based Cohort Study FRONTIERS IN ENDOCRINOLOGY, 2022, 13